PrEP Decision Support Tool for Young Adults in Alabama and Botswana
Part of Immune system & allergy, Infections clinical trials.
This study tests a new computer tool designed to help young adults and healthcare providers make better decisions about PrEP (a daily pill that prevents HIV). Researchers want to understand how this tool works in real clinics in Alabama and Botswana.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You must be HIV-negative (not have HIV)
- For Alabama: you are currently taking PrEP or eligible to start it
- For Botswana: you participated in a previous study called Tshireletso
- You are willing to help test a new clinic decision-support tool
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps connect young people aged 13–24 to PrEP, a daily pill that prevents HIV. It tests whether offering PrEP in clinics or community locations makes it easier for you to get and stay on this prevention medication.
This trial tests a “one-stop” support pathway meant to make it easier for PrEP clinics in Kenya to deliver PrEP care. It involves interviews with people using PrEP services and with healthcare and policy leaders who help run or guide PrEP delivery.
This study tests a tool to help Black women decide if PrEP (a daily pill to prevent HIV) is right for them. It may help you learn more about HIV prevention options.
This study offers a way for adolescent girls and young women in Tanzania to get PrEP (a daily pill that helps prevent HIV) from local pharmacies instead of only from clinics. It aims to make starting and staying on PrEP easier and more convenient.
This trial trains primary care providers at certain clinics to better offer PrEP, a daily pill that prevents HIV, to adolescents and young adults. If you are a provider at one of the listed clinics, you may be able to help improve how this prevention is delivered.
This study looks at whether people already taking PrEP (a daily pill to prevent HIV) can share HIV self-test kits and PrEP information with friends or others in their social network. It may help you if you are on PrEP and want to help others learn about HIV prevention.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.